Share and Share Alike | GenomeWeb

Share and Share Alike

The biotech industry is important for the creation of new drugs, job growth, and the health of the overall economy, but companies in this sector have continually found it challenging to raise the money they need to operate, says biopharmaceutical investment professional Mark Kessel in The Scientist. One solution, he says, would be for big pharma to create a biotech fund that utilizes pharma's cash to support biotech where needed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

For the Win

Now Up, After a Down

Building up Genomics

Define Your Terms

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.